dual-antiplatelet therapy

Original Contribution

Initial Experience of Bioabsorbable Polymer Everolimus-Eluting Synergy Stents in High-Risk Patients Undergoing Complex Percutaneous Coronary Intervention With Early Discontinuation of Dual-Antiplatelet Therapy

12/15/2016

Rebecca L. Noad, MB, PhD; Colm G. Hanratty, MD; Simon J. Walsh, MD

Rebecca L. Noad, MB, PhD; Colm G. Ha...

Synergy stents (Boston Scientific) allow for early cessation of DAPT. This study assessed those in our unit who underwent PCI with a Synergy stent to examine a minimum of 6 months of clinical outcomes after early discontinuation of DAPT.

Synergy stents (Boston...

12/15/2016

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

See Full Calendar

dual-antiplatelet therapy

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products